A model for evaluating topical antimicrobial efficacy against methicillin-resistant Staphylococcus aureus biofilms in superficial murine wounds

Antimicrob Agents Chemother. 2012 Aug;56(8):4508-10. doi: 10.1128/AAC.00467-12. Epub 2012 May 29.

Abstract

A wound biofilm model was created by adapting a superficial infection model. Partial-thickness murine wounds were inoculated with methicillin-resistant Staphylococcus aureus (MRSA). Dense biofilm communities developed at the wound surface after 24 h as demonstrated by microscopy and quantitative microbiology. Common topical antimicrobial agents had reduced efficacy when treatment was initiated 24 h after inoculation compared to 4 h after inoculation. This model provides a rapid in vivo test for new agents to treat wound biofilm infections.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Topical
  • Animals
  • Anti-Infective Agents, Local / administration & dosage*
  • Anti-Infective Agents, Local / pharmacology
  • Bacitracin / administration & dosage
  • Bacitracin / pharmacology
  • Biofilms / drug effects*
  • Methicillin-Resistant Staphylococcus aureus / drug effects*
  • Methicillin-Resistant Staphylococcus aureus / physiology
  • Mice
  • Mupirocin / administration & dosage
  • Mupirocin / pharmacology
  • Silver Compounds / administration & dosage
  • Silver Compounds / pharmacology
  • Silver Sulfadiazine / administration & dosage
  • Silver Sulfadiazine / pharmacology
  • Wound Infection / drug therapy
  • Wound Infection / microbiology*

Substances

  • Anti-Infective Agents, Local
  • Silver Compounds
  • Bacitracin
  • Mupirocin
  • Silver Sulfadiazine